Merus NV
Merus NV, a clinical‐stage immuno‑oncology company headquartered in Utrecht, develops bispecific antibody therapeutics including BIZENGRI and MCLA‑158 for solid tumors, and benefits from collaborations with Lilly, Ono and Betta while operating as a Genmab subsidiary.
Headquarters: United States (USA)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Hospitals and Health Care
- Industry: Medical and Diagnostic Laboratories
- Employees: 260
- HQ: Utrecht
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.